newsfilter
← Latest News
Business Wire·

AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)

  • AN2 Therapeutics granted inducement equity awards to two newly hired employees on October 19, 2026.
  • The awards consist of 10,565 non-qualified stock options & 5,283 restricted stock units (RSUs).
  • The stock options have an exercise price of $3.37 per share, based on the Nasdaq closing price on the grant date.
  • Stock option vesting begins after one year, with 1/48th of the grant vesting monthly thereafter.
  • RSUs vest annually over a four-year period subject to continuous service with the company.
  • The awards were approved by the Compensation Committee under Nasdaq Listing Rule 5635(c)(4) & the 2026 Employment Inducement Award Plan.